The post CVS Health Completes Purchase Of Rite Aids, Adds 9 Million Customers appeared on BitcoinEthereumNews.com. CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday. In this photo is a newly converted former Rite Aid store that is now a CVS in Edmonds, Wash. CVS Health CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday. The acquisition follows a bidding process and the completion of regulatory hurdles following Rite Aid’s bankruptcy filing earlier this year. It was the second bankruptcy filing for Rite Aid in less than two years. By buying the prescription files, CVS and Walgreens and others that purchased Rite Aid assets during the bankruptcy proceedings avoided taking on more debt from brick-and-mortar stores. It’s common for pharmacy chains, other retailers and grocers in the pharmacy business to pursue prescription files and related pharmacy assets during Chapter 11 bankruptcy proceedings. CVS is therefore now operating 63 former Rite Aid and Bartell Drugs and also acquired the prescription files of 626 former Rite Aid and Bartell Drugs pharmacies in 15 states. CVS said it hired more than 3,500 former Rite Aid and Bartell Drug employees as part of the acquisition and store conversions. Financial terms of the acquisitions weren’t disclosed. “We’re excited to have completed the acquisition of select Rite Aid and Bartell Drugs stores in the Pacific Northwest, as well as the acquisition of prescription files of hundreds of Rite Aid and Bartell Drugs pharmacies across 15 states,” said Len Shankman, Executive Vice President and President, Pharmacy and Consumer Wellness, CVS Health. “We’re helping maintain and expand access to convenient and trusted pharmacy care… The post CVS Health Completes Purchase Of Rite Aids, Adds 9 Million Customers appeared on BitcoinEthereumNews.com. CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday. In this photo is a newly converted former Rite Aid store that is now a CVS in Edmonds, Wash. CVS Health CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday. The acquisition follows a bidding process and the completion of regulatory hurdles following Rite Aid’s bankruptcy filing earlier this year. It was the second bankruptcy filing for Rite Aid in less than two years. By buying the prescription files, CVS and Walgreens and others that purchased Rite Aid assets during the bankruptcy proceedings avoided taking on more debt from brick-and-mortar stores. It’s common for pharmacy chains, other retailers and grocers in the pharmacy business to pursue prescription files and related pharmacy assets during Chapter 11 bankruptcy proceedings. CVS is therefore now operating 63 former Rite Aid and Bartell Drugs and also acquired the prescription files of 626 former Rite Aid and Bartell Drugs pharmacies in 15 states. CVS said it hired more than 3,500 former Rite Aid and Bartell Drug employees as part of the acquisition and store conversions. Financial terms of the acquisitions weren’t disclosed. “We’re excited to have completed the acquisition of select Rite Aid and Bartell Drugs stores in the Pacific Northwest, as well as the acquisition of prescription files of hundreds of Rite Aid and Bartell Drugs pharmacies across 15 states,” said Len Shankman, Executive Vice President and President, Pharmacy and Consumer Wellness, CVS Health. “We’re helping maintain and expand access to convenient and trusted pharmacy care…

CVS Health Completes Purchase Of Rite Aids, Adds 9 Million Customers

CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday. In this photo is a newly converted former Rite Aid store that is now a CVS in Edmonds, Wash.

CVS Health

CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain said Wednesday.

The acquisition follows a bidding process and the completion of regulatory hurdles following Rite Aid’s bankruptcy filing earlier this year. It was the second bankruptcy filing for Rite Aid in less than two years.

By buying the prescription files, CVS and Walgreens and others that purchased Rite Aid assets during the bankruptcy proceedings avoided taking on more debt from brick-and-mortar stores. It’s common for pharmacy chains, other retailers and grocers in the pharmacy business to pursue prescription files and related pharmacy assets during Chapter 11 bankruptcy proceedings.

CVS is therefore now operating 63 former Rite Aid and Bartell Drugs and also acquired the prescription files of 626 former Rite Aid and Bartell Drugs pharmacies in 15 states. CVS said it hired more than 3,500 former Rite Aid and Bartell Drug employees as part of the acquisition and store conversions. Financial terms of the acquisitions weren’t disclosed.

“We’re excited to have completed the acquisition of select Rite Aid and Bartell Drugs stores in the Pacific Northwest, as well as the acquisition of prescription files of hundreds of Rite Aid and Bartell Drugs pharmacies across 15 states,” said Len Shankman, Executive Vice President and President, Pharmacy and Consumer Wellness, CVS Health. “We’re helping maintain and expand access to convenient and trusted pharmacy care across the U.S. and growing our retail footprint and presence in local communities. From our innovative pharmacy care programs to our exclusive store brand products, we look forward to showing Rite Aid and Bartell Drugs patients and customers all that CVS has to offer.”

Source: https://www.forbes.com/sites/brucejapsen/2025/10/15/cvs-health-completes-purchase-of-rite-aids-adds-9-million-customers/

Market Opportunity
ritestream Logo
ritestream Price(RITE)
$0.000442
$0.000442$0.000442
+0.91%
USD
ritestream (RITE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

House Judiciary Rejects Vote To Subpoena Banks CEOs For Epstein Case

House Judiciary Rejects Vote To Subpoena Banks CEOs For Epstein Case

The post House Judiciary Rejects Vote To Subpoena Banks CEOs For Epstein Case appeared on BitcoinEthereumNews.com. Topline House Judiciary Committee Republicans blocked a Democrat effort Wednesday to subpoena a group of major banks as part of a renewed investigation into late sex offender Jeffrey Epstein’s financial ties. Congressman Jim Jordan, R-OH, is the chairman of the committee. (Photo by Nathan Posner/Anadolu via Getty Images) Anadolu via Getty Images Key Facts A near party-line vote squashed the effort to vote on a subpoena, with Rep. Thomas Massie, R-Ky., who is leading a separate effort to force the Justice Department to release more Epstein case materials, voting alongside Democrats. The vote, if successful, would have resulted in the issuing of subpoenas to JPMorgan Chase CEO Jamie Dimon, Bank of America CEO Brian Moynihan, Deutsche Bank CEO Christian Sewing and Bank of New York Mellon CEO Robin Vince. The subpoenas would have specifically looked into multiple reports that claimed the four banks flagged $1.5 billion in suspicious transactions linked to Epstein. The failed effort from Democrats followed an FBI oversight hearing in which agency director Kash Patel misleadingly claimed the FBI cannot release many of the files it has on Epstein. Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here. Crucial Quote Dimon, who attended a lunch with Senate Republicans before the vote, according to Politico, told reporters, “We regret any association with that man at all. And, of course, if it’s a legal requirement, we would conform to it. We have no issue with that.” Chief Critic “Republicans had the chance to subpoena the CEOs of JPMorgan, Bank of America, Deutsche Bank, and Bank of New York Mellon to expose Epstein’s money trail,” the House Judiciary Democrats said in a tweet. “Instead, they tried to bury…
Share
BitcoinEthereumNews2025/09/18 08:02
Propel to Report Q4 and Full Year 2025 Financial Results and Announces Dividend Increase

Propel to Report Q4 and Full Year 2025 Financial Results and Announces Dividend Increase

TORONTO, Feb. 10, 2026 /CNW/ – Propel Holdings Inc. (“Propel”) (TSX: PRL), the fintech facilitating access to credit for underserved consumers, announced today
Share
AI Journal2026/02/11 09:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56